投資評等
最後更新日期:2024/11/27
升級(Upgrade)
日期/Date | 券商 Brokerage Firm | 原評等->升級後評等 Upgrade from: -> to: | 新目標價 New Target |
2015/1/23 | BB&T Capital Mkts | Hold >> Buy | |
2014/6/10 | RBC Capital Mkts | Sector Perform >> Outperform | $97 >> $115 |
2012/3/15 | Barclays Capital | Equal Weight >> Overweight | $126 >> $133 |
2011/9/15 | UBS | Neutral >> Buy | $113 >> $110 |
2010/11/15 | Robert W. Baird | Neutral >> Outperform | $100 >> $120 |
2010/10/22 | Argus | Hold >> Buy | 99 |
2009/11/3 | Robert W. Baird | Neutral >> Outperform | 72 |
2006/7/25 | Stifel Nicolaus | Hold Buy | 109 |
2006/6/2 | UBS | Neutral Buy | |
2006/5/16 | BB&T Capital Mkts | Hold Buy | 115 |
2006/4/21 | Bear Stearns | Underperform Peer Perform | |
2005/3/17 | Bear Stearns | Underperform->Peer Perform | |
2005/2/18 | Morgan Stanley | Equal-weight->Overweight | 70 |
2005/1/25 | Morgan Stanley | Underweight->Equal-weight | |
2003/11/3 | UBS | Neutral -> Buy | |
2003/10/28 | Bear Stearns | Peer Perform -> Outperform | |
2003/5/5 | Prudential | Hold -> Buy | |
2003/5/5 | Prudential | Hold -> Buy | |
2003/3/14 | Salomon Smth Brny | In-line -> Outperform | |
2003/2/13 | UBS Warburg | Neutral -> Buy | 65 |
2002/12/6 | Bear Stearns | Underperform -> Ree -> Rerform | 65 |
降級(Downgrade)
日期/Date | 券商 Brokerage Firm | 原評等->降級後評等 Upgrade from: -> to: | 新目標價 New Target |
2015/10/5 | Barclays | Overweight >> Equal Weight | $108 >> $92 |
2012/7/20 | RBC Capital Mkts | Outperform >> Sector Perform | $134 >> $128 |
2011/2/16 | BMO Capital Markets | Outperform >> Market Perform | |
2010/10/22 | Robert W. Baird | Outperform >> Neutral | $92 >> $93 |
2009/11/24 | UBS | Buy >> Neutral | |
2006/1/20 | Citigroup | Hold Sell | |
2005/10/21 | Bear Stearns | Peer Perform->Underperform | |
2005/7/15 | JP Morgan | Neutral->Underweight | |
2005/1/20 | CSFB | Neutral->Underperform | 60 |
2005/1/4 | Bear Stearns | Peer Perform->Underperform | |
2004/12/9 | Merrill Lynch | Buy->Neutral | |
2004/10/28 | Wells Fargo Sec | Buy->Hold | |
2004/10/13 | UBS | Buy->Neutral | |
2004/3/24 | Morgan Stanley | Equal-weight->Underweight | |
2004/1/7 | Smith Barney Citigroup | Buy->Hold | |
2003/9/25 | Morgan Stanley | Overweight -> Equal-weight | |
2002/10/16 | Bear Stearns | Pee -> Rerform -> Underperform | |
首次予以評等(Coverage Initiated)
日期/Date | 券商 Brokerage Firm | 原評等->升級後評等 Upgrade from: -> to: | 目標股價 |
2014/10/14 | UBS | Buy | 123 |
2010/4/7 | FBR Capital | Outperform | |
2009/10/1 | Deutsche Securities | Buy | 68 |
2009/8/26 | Robert W. Baird | Neutral | 72 |
2007/1/23 | Calyon Securities | Neutral | 91 |
2005/8/17 | CSFB | Outperform | 80 |
2004/5/12 | Legg Mason | Hold | |
2004/1/29 | Avondale Partners | Mkt Outperform | 76 |
2003/6/6 | JP Morgan | Neutral | |
2003/4/8 | Fulcrum | Buy | |
恢復投資評等(Coverage Resumed)
日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
2002/9/13 | Merrill Lynch | Buy | 70 |
重申相同投資評等(Coverage Reiterated)
日期/Date | 券商 Brokerage Firm | 重申相同投資評等 Reiterated Rating | 新目標價 New Target |
2015/10/22 | Cowen | Outperform | $105 >> $103 |
2015/7/24 | UBS | Buy | $113 >> $107 |
2014/12/12 | Argus | Buy | $104 >> $130 |
2014/12/8 | Argus | Buy | $104 >> $130 |
2014/10/24 | FBR Capital | Outperform | $120 >> $130 |
2014/5/13 | Argus | Buy | $193 >> $208 |
2014/4/17 | Cowen | Outperform | $196 >> $197 |
2014/3/17 | Barclays | Overweight | $195 >> $205 |
2013/12/2 | Barclays | Overweight | $191 >> $195 |
2013/10/17 | Cowen | Outperform | $174 >> $170 |